University of Milan, post-graduate school of pathology, National Cancer Institute Milan, Editor-in-Chief Tumori Journal
Milano, Lombardia
Joined March 2021
- Tweets69
- Following90
- Followers58
- Likes8
Giancarlo Pruneri retweeted
Fantastic to see What Do We Know & What Should We Do About #FakeNews? by @NickAnstead featured on @LSEImpactBlog's 2021 in review!
'A solid touchpoint for people looking to understand one of the most pressing issues of our time.'
Get your copy here: bit.ly/3sT6g1G
Giancarlo Pruneri retweeted
Over 1200 papers submitted to @TumoriJ in 2021‼️
🙏Thanking to our #sectioneditors, #reviewers and #authors, TJ team wishes happy and prosperous #NewYear2022 🍾🥂
journals.sagepub.com/home/tm…
Giancarlo Pruneri retweeted
As 2021 comes to a close, we are featuring our top social media posts as chosen by you, our followers. Follow this week-long series and be sure to check out any of the posts you may have missed this year! cancer.gov/ #BestOf2021 #NCIHighlights2021 #NothingWillStopUs
Giancarlo Pruneri retweeted
Neoadjuvant chemotherapy💊 followed by interval debulking surgery for unresectable stage IVB Serous #endometrialcancer👇
#TJArchive🆓
journals.sagepub.com/doi/ful…
@PayamKashiMD @kahramanogluiMD @VCCLibrary @Mikhail_MIGS #GynecologicOncology #GYNOnc
Giancarlo Pruneri retweeted
Reminder to all pathologists and oncologists interested in digital transformation of pathology laboratories: the ESO-ESP Digital Pathology Seminar will be held on 11/12 DECEMBER 2021. Registration is FREE but mandatory 👉bit.ly/3BmqPnN. @ESP_Pathology #ESOexperience
Giancarlo Pruneri retweeted
🎙️“Based on a true story" #podcast: a #journey into the world of young patients w/ cancer🚶♀️🚶👩🦽🚶♂️ by A Ferrari et al
#YouthProject @IstTumori tends to clinical and psychological needs of #adolescent #AYA pts
▶️journals.sagepub.com/share/T…
@Radio24_news @Signoroni @carloaclerici
Giancarlo Pruneri retweeted
#TNBC revolution: not so negative any more‼️
Expanding targets: g/sBRCA1/2mut, gPALB2mut,TROP2, PD-L1+, HER2low, HER3, ERBB2mut, AKT1mut, NTRK, TMB-high, MSI-H
Expanding options: pembro, atezo (EU), sacituzumab, olaparib, talazoparib
Read more rdcu.be/cA5e5
#bcsm
Giancarlo Pruneri retweeted
✍️Most cited #TumoriJournal articles
Updating novel #inflammasome pathway-targeting agents for #immunotherapy and target therapy ➕ future research directions of inflammasome-based #targettherapy 🎯💊
🔓journals.sagepub.com/share/D…
@inflammasomelab @WuLabHarvard @carmonation
Giancarlo Pruneri retweeted
"#Fasting mimicking diet reshapes anticancer #immunity by inducing contraction of peripheral blood immunosuppressive myeloid/T-reg, enhanced intratumor Th1/cytotoxic responses & enrichment of signatures associated with better clinical outcomes in #cancer pts" @PruneriG @OncoAlert
#Fasting-mimicking diet (FMD) is safe and reshapes #metabolism and antitumor immunity in #cancer patients.
Eagerly awaited results of an important study which pave the way for the clinical implementation of FMD.
Congratulations to Claudio and co-authors!! cancerdiscovery.aacrjournals…
Giancarlo Pruneri retweeted
Last chance to register!
Don't forget to join our free webinar on prostate cancer open to everyone on Wednesday!
📅November 24, 2021
⏰1-2pm CET
More info: ow.ly/2xNG50GGbm5
#Movember #CancerResearch @OncoAlert
Giancarlo Pruneri retweeted
✨✨🧙 Illusionist techniques as a complement to psychological support for children with cancer
Preliminary descriptive experience by @carloaclerici et al @IstTumori
🔓
journals.sagepub.com/doi/ful…
#WorldChildrensDay #PediatricOncology #ChildhoodCancer #PsyOnc @WorldSIOP
Giancarlo Pruneri retweeted
📢Proud to present our manuscript 'Treatment landscape of triple-negative breast cancer — expanded options, evolving needs' which has just been published with @SpringerNature in @NatRevClinOncol
If you are intrested read here: rdcu.be/cA5e5
#bcsm #TNBC
@OncoAlert
Giancarlo Pruneri retweeted
#PathTwitter Happy #InternationalPathologyDay 2⃣0⃣2⃣1⃣! 🎀🎈🎈🔬🔬🔬
Many ESP affiliated National Societies and other Pathology institutions organise events and press releases to advertise the role of Pathology in modern Medicine!
#pathology
Giancarlo Pruneri retweeted
Predatory publishers adopt tactics of bootlegged articles & rebranding to feed fake open access journals and cheat researchers ⚠️
On @Nature, @KyleSile @philvlam @csugimoto @lariviev dig deep into the Hydra phenomenon, suggesting how to stop it 👇
nature.com/articles/d41586-0…
Giancarlo Pruneri retweeted
📌11-12 Dec | @EloyCatarina and @PruneriG, #TumoriJournal EiC, will be Co-Chairs of the @ESOncology & @ESP_Pathology Digital Pathology Seminar focused on digital transformation of #pathology laboratorie and consequent benefits🎯
Free of charge, program👇
e-eso.net/courses/21DPA
Giancarlo Pruneri retweeted
🔔 #OpenAccessWeek
👩💻 Discover the services and guarantees of a legitimate scientific publisher 📚
Avoid the risk of a predator🐊
#OAWeek2021
#openaccessweek2021
Today marks the beginning of #OAWeek2021 🎉
For over a decade we have played an active role in Open Access, seeking to build bridges to knowledge in the research community.
Visit our #OA homepage to discover more:
ow.ly/jsyg50Gv7HF
Giancarlo Pruneri retweeted
📍24 Oct 9.45 #AIOMCongress 🇮🇹 | Symposium #GenomicTests ➡️validation, scientific evidence and selection criteria #bcsm
Here @PruneriG and CA Tondini: The use of genomic tests in patients w/ #breastcancer in Lombardy: a successful healthcare model
👇
journals.sagepub.com/share/I…
Giancarlo Pruneri retweeted
Online first: Effect of #COVID19 #pandemic #lockdowns on planned #cancer #surgery for 15 tumour types in 61 countries @DrJamesGlasbey @aneelbhangu @COVIDSurg
thelancet.com/journals/lanon…